Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileSteven J. Russell, M.D.

TitleAssociate Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Diabetes Research Center, 3-301
50 Staniford Street
Boston MA 02114
Phone617/726-1848
Fax617/643-0697
vCardDownload vCard (login for email)

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
UC4DK108612     (DAMIANO, EDWARD)Sep 30, 2015 - Sep 29, 2019
NIH/NIDDK
Final clinical studies for submission of a pre-market approval application to the FDA for a Bionic Pancreas that automates type 1 diabetes management
Role: Co-Principal Investigator

DP3DK101084     (DAMIANO, EDWARD)Sep 30, 2013 - Aug 31, 2016
NIH/NIDDK
A multicenter outpatient trial of a bihormonal bionic pancreas
Role: Co-Principal Investigator

R01DK097657     (DAMIANO, EDWARD)May 1, 2013 - Jan 31, 2017
NIH/NIDDK
Translatioanl studies of a bionic pancreas for out-patient diabetes management
Role: Co-Principal Investigator

K08AG032869     (RUSSELL, STEVEN J)Aug 15, 2008 - Jul 31, 2013
NIH/NIA
Adipocyte insulin signaling in metabolism and aging
Role: Principal Investigator

F32AG028265     (RUSSELL, STEVEN J)Jun 30, 2006 - Jun 29, 2007
NIH/NIA
Adipocyte insulin signaling in metabolism and aging
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Chan SKK, Cerda-Moya G, Stojnic R, Millen K, Fischer B, Fexova S, Skalska L, Gomez-Lamarca M, Pillidge Z, Russell S, Bray SJ. Role of co-repressor genomic landscapes in shaping the Notch response. PLoS Genet. 2017 Nov; 13(11):e1007096. PMID: 29155828.
    View in: PubMed
  2. Weissberg-Benchell J, Hessler D, Fisher L, Russell SJ, Polonsky WH. Impact of an Automated Bihormonal Delivery System on Psychosocial Outcomes in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 Dec; 19(12):723-729. PMID: 29106311.
    View in: PubMed
  3. Miller A, Asmann Y, Cattaneo L, Braggio E, Keats J, Auclair D, Lonial S, Russell SJ, Stewart AK. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma. Blood Cancer J. 2017 Sep 22; 7(9):e612. PMID: 28937974.
    View in: PubMed
  4. Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, Go RS, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Kumar SK. Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains. Leukemia. 2018 Mar; 32(3):729-735. PMID: 28919633.
    View in: PubMed
  5. Binder M, Rajkumar SV, Ketterling RP, Greipp PT, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kyle RA, Kumar SK. Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma. Blood Cancer J. 2017 Sep 01; 7(9):e600. PMID: 28862698.
    View in: PubMed
  6. Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB. Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016. JAMA Oncol. 2017 Sep 01; 3(9):1257-1265. PMID: 28056114.
    View in: PubMed
  7. Lakshman A, Alhaj Moustafa M, Rajkumar SV, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Natural history of t(11;14) multiple myeloma. Leukemia. 2018 Jan; 32(1):131-138. PMID: 28655925.
    View in: PubMed
  8. Russell SJ. Artificial pancreas research: you can observe a lot by watching. Lancet Diabetes Endocrinol. 2017 Jul; 5(7):484-485. PMID: 28533139.
    View in: PubMed
  9. Sinha M, McKeon KM, Parker S, Goergen LG, Zheng H, El-Khatib FH, Russell SJ. A Comparison of Time Delay in Three Continuous Glucose Monitors for Adolescents and Adults. J Diabetes Sci Technol. 2017 Nov; 11(6):1132-1137. PMID: 28459159.
    View in: PubMed
  10. Dispenzieri A, Tong C, LaPlant B, Lacy MQ, Laumann K, Dingli D, Zhou Y, Federspiel MJ, Gertz MA, Hayman S, Buadi F, O'Connor M, Lowe VJ, Peng KW, Russell SJ. Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma. Leukemia. 2017 Dec; 31(12):2791-2798. PMID: 28439108.
    View in: PubMed
  11. Muchtar E, Dispenzieri A, Kumar SK, Buadi FK, Lacy MQ, Zeldenrust S, Hayman SR, Leung N, Kourelis TV, Gonsalves W, Chakraborty R, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Kyle RA, Rajkumar SV, Gertz MA. Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival. Amyloid. 2017 Mar; 24(sup1):40-41. PMID: 28434371.
    View in: PubMed
  12. Kahanovitz L, Sluss PM, Russell SJ. Type 1 Diabetes - A Clinical Perspective. Point Care. 2017 Mar; 16(1):37-40. PMID: 28943810.
    View in: PubMed
  13. Muchtar E, Dispenzieri A, Kumar SK, Buadi FK, Lacy MQ, Zeldenrust S, Hayman SR, Leung N, Chakraborty R, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Kyle RA, Rajkumar VS, Gertz MA. Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type. Amyloid. 2017 Mar; 24(sup1):44-45. PMID: 28434304.
    View in: PubMed
  14. Tandon N, Rajkumar SV, LaPlant B, Pettinger A, Lacy MQ, Dispenzieri A, Buadi FK, Gertz MA, Hayman SR, Leung N, Go RS, Dingli D, Kapoor P, Lin Y, Hwa YL, Fonder AL, Hobbs MA, Zeldenrust SR, Lust JA, Gonsalves WI, Russell SJ, Kumar SK. Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma. Blood Cancer J. 2017 02 17; 7(2):e528. PMID: 28211889.
    View in: PubMed
  15. El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet. 2017 01 28; 389(10067):369-380. PMID: 28007348.
    View in: PubMed
  16. Ekhlaspour L, Mondesir D, Lautsch N, Balliro C, Hillard M, Magyar K, Radocchia LG, Esmaeili A, Sinha M, Russell SJ. Comparative Accuracy of 17 Point-of-Care Glucose Meters. J Diabetes Sci Technol. 2017 May; 11(3):558-566. PMID: 27697848.
    View in: PubMed
  17. Gonsalves WI, Rajkumar SV, Dispenzieri A, Dingli D, Timm MM, Morice WG, Lacy MQ, Buadi FK, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa L, Kourelis TV, Kyle RA, Gertz MA, Kumar SK. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression. Leukemia. 2017 Jan; 31(1):130-135. PMID: 27457702.
    View in: PubMed
  18. Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, DeVries JH, Doyle FJ, Griffen SC, Haidar A, Heinemann L, Hovorka R, Jones TW, Kollman C, Kovatchev B, Levy BL, Nimri R, O'Neal DN, Philip M, Renard E, Russell SJ, Weinzimer SA, Zisser H, Lum JW. Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report. Diabetes Care. 2016 07; 39(7):1175-9. PMID: 27330126; PMCID: PMC4915553 [Available on 07/01/17].
  19. Russell SJ, Beck RW. Design Considerations for Artificial Pancreas Pivotal Studies. Diabetes Care. 2016 07; 39(7):1161-7. PMID: 27330125.
    View in: PubMed
  20. Kahanovitz L, Seker E, Marks RS, Yarmush ML, Konry T, Russell SJ. Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring. J Diabetes Sci Technol. 2016 05; 10(3):689-96. PMID: 26721524.
    View in: PubMed
  21. Gonsalves WI, Rajkumar SV, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa YL, Kourelis TV, Kyle RA, Kumar SK. Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy. Bone Marrow Transplant. 2016 08; 51(8):1156-8. PMID: 27064687.
    View in: PubMed
  22. Russell SJ, Hillard MA, Balliro C, Magyar KL, Selagamsetty R, Sinha M, Grennan K, Mondesir D, Ekhlaspour L, Zheng H, Damiano ER, El-Khatib FH. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol. 2016 Mar; 4(3):233-243. PMID: 26850709.
    View in: PubMed
  23. Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Hwa YL, Gonsalves W, Kyle RA, Dispenzieri A. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment. Leukemia. 2016 05; 30(5):1079-85. PMID: 26669974.
    View in: PubMed
  24. Russell SJ. Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Curr Opin Endocrinol Diabetes Obes. 2015 Apr; 22(2):106-11. PMID: 25692927; PMCID: PMC4383642.
  25. Gonsalves WI, Leung N, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Kapoor P, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust S, Kyle RA, Gertz MA, Kumar SK. Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Blood Cancer J. 2015 Mar 20; 5:e296. PMID: 25794132; PMCID: PMC4382661.
  26. Russell SJ. When you come to a fork in the road, take it! Lancet Diabetes Endocrinol. 2015 Jan; 3(1):2-3. PMID: 25434966.
    View in: PubMed
  27. Magbanua JP, Runneburger E, Russell S, White R. A variably occupied CTCF binding site in the ultrabithorax gene in the Drosophila bithorax complex. Mol Cell Biol. 2015 Jan; 35(1):318-30. PMID: 25368383; PMCID: PMC4295388.
  28. Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014 Jul 24; 371(4):313-325. PMID: 24931572; PMCID: PMC4183762.
  29. Suksanpaisan L, Russell SJ, Peng KW. High scFv-receptor affinity does not enhance the antitumor activity of HER2-retargeted measles virus. Cancer Gene Ther. 2014 Jun; 21(6):256-60. PMID: 24874841; PMCID: PMC4096840.
  30. Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol. 2014 Jul; 8(4):699-708. PMID: 24876423; PMCID: PMC4764229.
  31. El-Khatib FH, Russell SJ, Magyar KL, Sinha M, McKeon K, Nathan DM, Damiano ER. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab. 2014 May; 99(5):1701-11. PMID: 24483160; PMCID: PMC4010702.
  32. Jing Y, Zaias J, Duncan R, Russell SJ, Merchan JR. In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models. Gene Ther. 2014 Mar; 21(3):289-97. PMID: 24430235; PMCID: PMC3949200.
  33. Yarde DN, Naik S, Nace RA, Peng KW, Federspiel MJ, Russell SJ. Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Ther. 2013 Nov; 20(11):616-21. PMID: 24176894; PMCID: PMC3855306.
  34. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014 May; 28(5):1122-8. PMID: 24157580; PMCID: PMC4000285.
  35. Suksanpaisan L, Pham L, McIvor S, Russell SJ, Peng KW. Oral contrast enhances the resolution of in-life NIS reporter gene imaging. Cancer Gene Ther. 2013 Nov; 20(11):638-41. PMID: 24030210; PMCID: PMC3867790.
  36. Escobar-Zarate D, Liu YP, Suksanpaisan L, Russell SJ, Peng KW. Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors. Cancer Gene Ther. 2013 Oct; 20(10):582-9. PMID: 24030211; PMCID: PMC4817541.
  37. Li H, Nakashima H, Decklever TD, Nace RA, Russell SJ. HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy. Cancer Gene Ther. 2013 Aug; 20(8):478-85. PMID: 23868101; PMCID: PMC3747331.
  38. Touchefeu Y, Khan AA, Borst G, Zaidi SH, McLaughlin M, Roulstone V, Mansfield D, Kyula J, Pencavel T, Karapanagiotou EM, Clayton J, Federspiel MJ, Russell SJ, Garrett M, Collins I, Harrington KJ. Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. Radiother Oncol. 2013 Jul; 108(1):24-31. PMID: 23849174.
    View in: PubMed
  39. Uihlein A, Greenwald J, Russell SJ. Case 35-2012: A man with weakness, anorexia, and diffuse pain. N Engl J Med. 2013 Feb 28; 368(9):874-5. PMID: 23445105.
    View in: PubMed
  40. Nathan DM, Russell S. The future of care for type 1 diabetes. CMAJ. 2013 Mar 05; 185(4):285-6. PMID: 23359043; PMCID: PMC3589303.
  41. Lee KY, Russell SJ, Ussar S, Boucher J, Vernochet C, Mori MA, Smyth G, Rourk M, Cederquist C, Rosen ED, Kahn BB, Kahn CR. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes. 2013 Mar; 62(3):864-74. PMID: 23321074; PMCID: PMC3581196.
  42. Damiano ER, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care. 2013 Feb; 36(2):251-9. PMID: 23275350; PMCID: PMC3554299.
  43. Larkin ME, Beauharnais CC, Magyar K, Macey L, Grennan KB, Boykin EE, Russell SJ. Obtaining surrogate consent for a minimal-risk research study in the intensive care unit setting. Clin Trials. 2013 Feb; 10(1):93-6. PMID: 23169873.
    View in: PubMed
  44. Mori MA, Raghavan P, Thomou T, Boucher J, Robida-Stubbs S, Macotela Y, Russell SJ, Kirkland JL, Blackwell TK, Kahn CR. Role of microRNA processing in adipose tissue in stress defense and longevity. Cell Metab. 2012 Sep 05; 16(3):336-47. PMID: 22958919; PMCID: PMC3461823.
  45. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care. 2012 Nov; 35(11):2148-55. PMID: 22923666; PMCID: PMC3476884.
  46. Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Ther. 2012 Sep; 19(9):659-65. PMID: 22790962.
    View in: PubMed
  47. Boucher J, Mori MA, Lee KY, Smyth G, Liew CW, Macotela Y, Rourk M, Bluher M, Russell SJ, Kahn CR. Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nat Commun. 2012 Jun 12; 3:902. PMID: 22692545; PMCID: PMC3529640.
  48. Naik S, Nace R, Barber GN, Russell SJ. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-ß. Cancer Gene Ther. 2012 Jul; 19(7):443-50. PMID: 22522623; PMCID: PMC3380174.
  49. Peng KW, Myers R, Greenslade A, Mader E, Greiner S, Federspiel MJ, Dispenzieri A, Russell SJ. Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses. Gene Ther. 2013 Mar; 20(3):255-61. PMID: 22476202; PMCID: PMC3806053.
  50. Naik S, Nace R, Federspiel MJ, Barber GN, Peng KW, Russell SJ. Curative one-shot systemic virotherapy in murine myeloma. Leukemia. 2012 Aug; 26(8):1870-8. PMID: 22425894; PMCID: PMC3411853.
  51. Liu YP, Tong C, Dispenzieri A, Federspiel MJ, Russell SJ, Peng KW. Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus. Cancer Gene Ther. 2012 Mar; 19(3):202-11. PMID: 22116376; PMCID: PMC3288770.
  52. Penheiter AR, Griesmann GE, Federspiel MJ, Dingli D, Russell SJ, Carlson SK. Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors. Gene Ther. 2012 Mar; 19(3):279-87. PMID: 21753796; PMCID: PMC3198860.
  53. Frecha C, Lévy C, Costa C, Nègre D, Amirache F, Buckland R, Russell SJ, Cosset FL, Verhoeyen E. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. J Virol. 2011 Jun; 85(12):5975-85. PMID: 21450813; PMCID: PMC3126293.
  54. Russell SJ, El-Khatib FH, Nathan DM, Damiano ER. Efficacy determinants of subcutaneous microdose glucagon during closed-loop control. J Diabetes Sci Technol. 2010 Nov 01; 4(6):1288-304. PMID: 21129323; PMCID: PMC3005038.
  55. Lacy MQ, Hayman SR, Gertz MA, Short KD, Dispenzieri A, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Zeldenrust S, Fonseca R, Bergsagel PL, Roy V, Mikhael JR, Stewart AK, Laumann K, Allred JB, Mandrekar SJ, Rajkumar SV, Buadi F. Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia. 2010 Nov; 24(11):1934-9. PMID: 20827286; PMCID: PMC2978257.
  56. Ricci D, Mennander AA, Miyagi N, Rao VP, Tazelaar HD, Classic K, Byrne GW, Russell SJ, McGregor CG. Prolonged cardiac allograft survival using iodine 131 after human sodium iodide symporter gene transfer in a rat model. Transplant Proc. 2010 Jun; 42(5):1888-94. PMID: 20620544; PMCID: PMC2904983.
  57. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010 Apr 14; 2(27):27ra27. PMID: 20393188; PMCID: PMC4242106.
  58. Li H, Peng KW, Dingli D, Kratzke RA, Russell SJ. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Ther. 2010 Aug; 17(8):550-8. PMID: 20379224; PMCID: PMC2907639.
  59. Dingli D, Offord C, Myers R, Peng KW, Carr TW, Josic K, Russell SJ, Bajzer Z. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Ther. 2009 Dec; 16(12):873-82. PMID: 19498461; PMCID: PMC2821809.
  60. Ng AC, Kumar SK, Russell SJ, Rajkumar SV, Drake MT. Dexamethasone and the risk for adrenal suppression in multiple myeloma. Leukemia. 2009 May; 23(5):1009-11. PMID: 19151775; PMCID: PMC2893349.
  61. Russell SJ, Peng KW. Measles virus for cancer therapy. Curr Top Microbiol Immunol. 2009; 330:213-41. PMID: 19203112; PMCID: PMC3926122.
  62. Kwong C, Adryan B, Bell I, Meadows L, Russell S, Manak JR, White R. Stability and dynamics of polycomb target sites in Drosophila development. PLoS Genet. 2008 Sep 05; 4(9):e1000178. PMID: 18773083; PMCID: PMC2525605.
  63. Blechacz B, Russell SJ. Measles virus as an oncolytic vector platform. Curr Gene Ther. 2008 Jun; 8(3):162-75. PMID: 18537591.
    View in: PubMed
  64. Russell SJ. Continuous glucose monitoring awaits its "killer app". J Diabetes Sci Technol. 2008 May; 2(3):490-4. PMID: 19885216; PMCID: PMC2769737.
  65. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008 Jun; 73(11):1282-8. PMID: 18385667.
    View in: PubMed
  66. Liu C, Erlichman C, McDonald CJ, Ingle JN, Zollman P, Iankov I, Russell SJ, Galanis E. Heat shock protein inhibitors increase the efficacy of measles virotherapy. Gene Ther. 2008 Jul; 15(14):1024-34. PMID: 18356818; PMCID: PMC2748733.
  67. Munguia A, Ota T, Miest T, Russell SJ. Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth. Gene Ther. 2008 May; 15(10):797-806. PMID: 18356812.
    View in: PubMed
  68. Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E, Kahn CR. Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell. 2007 Dec; 6(6):827-39. PMID: 18001293.
    View in: PubMed
  69. Myers RM, Greiner SM, Harvey ME, Griesmann G, Kuffel MJ, Buhrow SA, Reid JM, Federspiel M, Ames MM, Dingli D, Schweikart K, Welch A, Dispenzieri A, Peng KW, Russell SJ. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Clin Pharmacol Ther. 2007 Dec; 82(6):700-10. PMID: 17971816; PMCID: PMC2769566.
  70. Dingli D, Russell SJ. Mouse models and the RANKL/OPG axis in myeloma bone disease. Leukemia. 2007 Oct; 21(10):2090-3. PMID: 17878922.
    View in: PubMed
  71. Russell SJ, Kahn CR. Endocrine regulation of ageing. Nat Rev Mol Cell Biol. 2007 Sep; 8(9):681-91. PMID: 17684529.
    View in: PubMed
  72. Russell ST, Eley H, Tisdale MJ. Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I). Cell Signal. 2007 Jul; 19(7):1583-95. PMID: 17376652.
    View in: PubMed
  73. Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao R, Kahn CR. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol. 2007 Mar; 27(5):1649-64. PMID: 17189427; PMCID: PMC1820447.
  74. Ong HT, Hasegawa K, Dietz AB, Russell SJ, Peng KW. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Gene Ther. 2007 Feb; 14(4):324-33. PMID: 17051248.
    View in: PubMed
  75. Russell SJ, Winnemuller L, Camp JE, Johnson PW. Comparing the results of five lifting analysis tools. Appl Ergon. 2007 Jan; 38(1):91-7. PMID: 16867298.
    View in: PubMed
  76. Peng KW, Hadac EM, Anderson BD, Myers R, Harvey M, Greiner SM, Soeffker D, Federspiel MJ, Russell SJ. Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Ther. 2006 Aug; 13(8):732-8. PMID: 16543921.
    View in: PubMed
  77. Page AR, Kovacs A, Deak P, Torok T, Kiss I, Dario P, Bastos C, Batista P, Gomes R, Ohkura H, Russell S, Glover DM. Spotted-dick, a zinc-finger protein of Drosophila required for expression of Orc4 and S phase. EMBO J. 2005 Dec 21; 24(24):4304-15. PMID: 16369566; PMCID: PMC1356331.
  78. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochim Biophys Acta. 2004 Feb 27; 1636(1):59-68. PMID: 14984739.
    View in: PubMed
  79. Sandrin V, Russell SJ, Cosset FL. Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol. 2003; 281:137-78. PMID: 12932077.
    View in: PubMed
  80. Larochelle A, Peng KW, Russell SJ. Lentiviral vector targeting. Curr Top Microbiol Immunol. 2002; 261:143-63. PMID: 11892245.
    View in: PubMed
  81. Peng KW, Pham L, Ye H, Zufferey R, Trono D, Cosset FL, Russell SJ. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 2001 Oct; 8(19):1456-63. PMID: 11593358.
    View in: PubMed
  82. Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ. Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood. 2001 Oct 01; 98(7):2002-7. PMID: 11567982.
    View in: PubMed
  83. Lavillette D, Russell SJ, Cosset FL. Retargeting gene delivery using surface-engineered retroviral vector particles. Curr Opin Biotechnol. 2001 Oct; 12(5):461-6. PMID: 11604321.
    View in: PubMed
  84. Russell SJ, Gonzalez F, Joshua-Tor L, Johnston SA. Selective chemical inactivation of AAA proteins reveals distinct functions of proteasomal ATPases. Chem Biol. 2001 Oct; 8(10):941-50. PMID: 11590019.
    View in: PubMed
  85. Gillette TG, Huang W, Russell SJ, Reed SH, Johnston SA, Friedberg EC. The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev. 2001 Jun 15; 15(12):1528-39. PMID: 11410533; PMCID: PMC312714.
  86. Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum Gene Ther. 2001 May 01; 12(7):811-21. PMID: 11339897.
    View in: PubMed
  87. DasGupta SF, Rapoport SI, Gerschenson M, Murphy E, Fiskum G, Russell SJ, Chandrasekaran K. ATP synthesis is coupled to rat liver mitochondrial RNA synthesis. Mol Cell Biochem. 2001 May; 221(1-2):3-10. PMID: 11506183.
    View in: PubMed
  88. Lavillette D, Boson B, Russell SJ, Cosset FL. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J Virol. 2001 Apr; 75(8):3685-95. PMID: 11264358; PMCID: PMC114860.
  89. Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol. 2001 Mar; 75(5):2087-96. PMID: 11160713; PMCID: PMC114793.
  90. Pham L, Ye H, Cosset FL, Russell SJ, Peng KW. Concentration of viral vectors by co-precipitation with calcium phosphate. J Gene Med. 2001 Mar-Apr; 3(2):188-94. PMID: 11318118.
    View in: PubMed
  91. Russell SJ, Johnston SA. Evidence that proteolysis of Gal4 cannot explain the transcriptional effects of proteasome ATPase mutations. J Biol Chem. 2001 Mar 30; 276(13):9825-31. PMID: 11152478.
    View in: PubMed
  92. Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R. Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol. 2000 Nov; 74(21):9928-36. PMID: 11024120; PMCID: PMC102030.
  93. Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Ther. 2000 Oct; 7(19):1656-63. PMID: 11083474.
    View in: PubMed
  94. Fielding AK, Chapel-Fernandes S, Chadwick MP, Bullough FJ, Cosset FL, Russell SJ. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Hum Gene Ther. 2000 Apr 10; 11(6):817-26. PMID: 10779159.
    View in: PubMed
  95. Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, Cattaneo R, Russell SJ, Vile RG. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 2000 Mar 15; 60(6):1492-7. PMID: 10749110.
    View in: PubMed
  96. Hatziioannou T, Russell SJ, Cosset FL. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins. Virology. 2000 Feb 01; 267(1):49-57. PMID: 10648182.
    View in: PubMed
  97. Lavillette D, Ruggieri A, Russell SJ, Cosset FL. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J Virol. 2000 Jan; 74(1):295-304. PMID: 10590117; PMCID: PMC111539.
  98. Russell SJ, Cosset FL. Modifying the host range properties of retroviral vectors. J Gene Med. 1999 Sep-Oct; 1(5):300-11. PMID: 10738547.
    View in: PubMed
  99. Russell SJ, Steger KA, Johnston SA. Subcellular localization, stoichiometry, and protein levels of 26 S proteasome subunits in yeast. J Biol Chem. 1999 Jul 30; 274(31):21943-52. PMID: 10419517.
    View in: PubMed
  100. Maurice M, Mazur S, Bullough FJ, Salvetti A, Collins MK, Russell SJ, Cosset FL. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins. Blood. 1999 Jul 15; 94(2):401-10. PMID: 10397706.
    View in: PubMed
  101. Hatziioannou T, Delahaye E, Martin F, Russell SJ, Cosset FL. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin. Hum Gene Ther. 1999 Jun 10; 10(9):1533-44. PMID: 10395378.
    View in: PubMed
  102. Russell SJ, Reed SH, Huang W, Friedberg EC, Johnston SA. The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol Cell. 1999 Jun; 3(6):687-95. PMID: 10394357.
    View in: PubMed
  103. Chadwick MP, Morling FJ, Cosset FL, Russell SJ. Modification of retroviral tropism by display of IGF-I. J Mol Biol. 1999 Jan 15; 285(2):485-94. PMID: 9878423.
    View in: PubMed
  104. Russell,SJ. Studies of SUG1 and SUG2, ATPases of the 26S Proteasome and Their Contributions to Proteolylsis, Nucleotide Excision Repair, and Gene Transcription. 1999.
  105. Lavillette D, Maurice M, Roche C, Russell SJ, Sitbon M, Cosset FL. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol. 1998 Dec; 72(12):9955-65. PMID: 9811733; PMCID: PMC110509.
  106. Buchholz CJ, Peng KW, Morling FJ, Zhang J, Cosset FL, Russell SJ. In vivo selection of protease cleavage sites from retrovirus display libraries. Nat Biotechnol. 1998 Oct; 16(10):951-4. PMID: 9788352.
    View in: PubMed
  107. Hatziioannou T, Valsesia-Wittmann S, Russell SJ, Cosset FL. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J Virol. 1998 Jun; 72(6):5313-7. PMID: 9573311; PMCID: PMC116395.
  108. Fielding AK, Maurice M, Morling FJ, Cosset FL, Russell SJ. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood. 1998 Mar 01; 91(5):1802-9. PMID: 9473249.
    View in: PubMed
  109. Morling FJ, Peng KW, Cosset FL, Russell SJ. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. Virology. 1997 Jul 21; 234(1):51-61. PMID: 9234946.
    View in: PubMed
  110. Hawkins RE, Russell SJ, Marcus R, Ashworth LJ, Brissnik J, Zhang J, Winter G, Bleehen NM, Shaw MM, Williamson L, Ouwehand W, Stevenson F, Hamblin T, Oscier D, Zhu D, King C, Kumar S, Thompsett A, Stevenson GT. A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027. Hum Gene Ther. 1997 Jul 01; 8(10):1287-99. PMID: 9215745.
    View in: PubMed
  111. Peng KW, Morling FJ, Cosset FL, Murphy G, Russell SJ. A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum Gene Ther. 1997 Apr 10; 8(6):729-38. PMID: 9113512.
    View in: PubMed
  112. Valsesia-Wittmann S, Morling FJ, Hatziioannou T, Russell SJ, Cosset FL. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J. 1997 Mar 17; 16(6):1214-23. PMID: 9135138; PMCID: PMC1169720.
  113. Russell SJ, Sathyanarayana UG, Johnston SA. Isolation and characterization of SUG2. A novel ATPase family component of the yeast 26 S proteasome. J Biol Chem. 1996 Dec 20; 271(51):32810-7. PMID: 8955118.
    View in: PubMed
  114. Ager S, Nilson BH, Morling FJ, Peng KW, Cosset FL, Russell SJ. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Hum Gene Ther. 1996 Nov 10; 7(17):2157-64. PMID: 8934229.
    View in: PubMed
  115. Cosset FL, Russell SJ. Targeting retrovirus entry. Gene Ther. 1996 Nov; 3(11):946-56. PMID: 8940634.
    View in: PubMed
  116. Nilson BH, Morling FJ, Cosset FL, Russell SJ. Targeting of retroviral vectors through protease-substrate interactions. Gene Ther. 1996 Apr; 3(4):280-6. PMID: 8732159.
    View in: PubMed
  117. Valsesia-Wittmann S, Morling FJ, Nilson BH, Takeuchi Y, Russell SJ, Cosset FL. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol. 1996 Mar; 70(3):2059-64. PMID: 8627737; PMCID: PMC190040.
  118. Cosset FL, Morling FJ, Takeuchi Y, Weiss RA, Collins MK, Russell SJ. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol. 1995 Oct; 69(10):6314-22. PMID: 7666532; PMCID: PMC189530.
  119. Russell SJ, Nisen PD. Random X chromosome inactivation in a female with a variant of Wiskott-Aldrich syndrome. Br J Haematol. 1995 May; 90(1):210-2. PMID: 7786787.
    View in: PubMed
  120. Russell SJ, Ye YW, Waber PG, Shuford M, Schold SC, Nisen PD. p53 mutations, O6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer. 1995 Mar 15; 75(6):1339-42. PMID: 7882284.
    View in: PubMed
  121. Plummer, BF, Currey, JA, Russell, SJ, Steffen, LK, Watson, WH, Bourne, SA. The Synthesis and X-ray Crystallographic Analysis of a Stable Norbornadienone: 17-oxo-7,16-methano-7,16-diphenylcyclopenta[d,e] tribenzo[a,h,j]antharacene. Struct Chem. 1995; 6:167-73.
  122. Hawkins RE, Russell SJ, Baier M, Winter G. The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme. J Mol Biol. 1993 Dec 20; 234(4):958-64. PMID: 8263942.
    View in: PubMed
  123. Russell SJ, Brandenburger A, Flemming CL, Collins MK, Rommelaere J. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol. 1992 May; 66(5):2821-8. PMID: 1560527; PMCID: PMC241039.
  124. Russell, IJ, Russell, SJ, Cuevas, RE, Michalek, JE, Murphy, DL. Early Life Traumas and Confiding In Fibromyalgia Syndrome. Arthritis and Rheumatism. 1992; 39:S90.
  125. Plummer, BF, Russell, SJ, Reese, WG, Watson, WH, Krawiec, M. . Sterically Congested Polycyclic Aromatic Hydrocarbons with Nonoptimal Geometries. 4,5-Didehydroacenapthene as a Precursor for the Synthesis of 7,14 Diphenyl-8,9-(1’,8’-naphthenylene)acephenanthrene. J Org Chem. 1991; 56:3219-23.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Russell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_